Liposome News and Research

Latest Liposome News and Research

Pacira launches EXPAREL in the U.S.

Pacira launches EXPAREL in the U.S.

Bio-Path 2011 net loss increases to $2,363,344

Bio-Path 2011 net loss increases to $2,363,344

New treatment approach halts spread of cancer cells into normal brain tissue

New treatment approach halts spread of cancer cells into normal brain tissue

Researchers design new treatment approach for invasive brain tumors

Researchers design new treatment approach for invasive brain tumors

Groundbreaking cystic fibrosis clinical trial to proceed after renewed funding

Groundbreaking cystic fibrosis clinical trial to proceed after renewed funding

New FSU technology could decrease the cost of drug discovery

New FSU technology could decrease the cost of drug discovery

Altogen launches new pancreas-targeted in vivo RNAi transfection system

Altogen launches new pancreas-targeted in vivo RNAi transfection system

Pacira provides updated timing for commercial launch of EXPAREL

Pacira provides updated timing for commercial launch of EXPAREL

Colby's JVRS-100 enhances immunogenicity, cross-protective efficacy of H5N1 influenza vaccine

Colby's JVRS-100 enhances immunogenicity, cross-protective efficacy of H5N1 influenza vaccine

New pharma title from iSmithers ‘Update on Polymers for Ocular Drug Delivery’

New pharma title from iSmithers ‘Update on Polymers for Ocular Drug Delivery’

Diseases of the Colon & Rectum publishes results from Pacira's EXPAREL Phase 3 trial

Diseases of the Colon & Rectum publishes results from Pacira's EXPAREL Phase 3 trial

Pacira prices public offering of 7,000,000 shares of common stock

Pacira prices public offering of 7,000,000 shares of common stock

Insmed third quarter revenues decrease to $0.4 million

Insmed third quarter revenues decrease to $0.4 million

Pacira's third quarter total revenues decrease to $4.0 million

Pacira's third quarter total revenues decrease to $4.0 million

FDA approves Pacira's EXPAREL for postsurgical pain management

FDA approves Pacira's EXPAREL for postsurgical pain management

Pacira announces data from EXPAREL clinical study presented at ASPS 2011 meeting

Pacira announces data from EXPAREL clinical study presented at ASPS 2011 meeting

Liposomes block HIV infection in early tests

Liposomes block HIV infection in early tests

ICS, Quintiles enter agreement with Pacira to support launch of EXPAREL

ICS, Quintiles enter agreement with Pacira to support launch of EXPAREL

Insmed second quarter revenues decrease to $1.0 million

Insmed second quarter revenues decrease to $1.0 million

Insmed receives FDA clinical hold order for ARIKACE phase 3 trials in CF and NTM

Insmed receives FDA clinical hold order for ARIKACE phase 3 trials in CF and NTM